Addex Therapeutics Ltd. (ADXN) Equity Average (2023 - 2024)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Addex Therapeutics' Equity Average history spans 2 years, with the latest figure at $6.2 million for Q4 2024.

• For Q4 2024, Equity Average rose 93.05% year-over-year to $6.2 million; the TTM value through Dec 2024 reached $6.2 million, up 93.05%, while the annual FY2024 figure was $6.1 million, 91.04% up from the prior year.
• Equity Average for Q4 2024 was $6.2 million at Addex Therapeutics, up from $3.2 million in the prior quarter.
• Across five years, Equity Average topped out at $6.2 million in Q4 2024 and bottomed at $3.2 million in Q4 2023.

Peer Comparison